Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
A randomized, double-blind, placebo-controlled study of histone deacetylase type 6 inhibition for the treatment of painful diabetic peripheral neuropathy.
Journal: Pain reports
Published: April 27, 2023
Looking for Drugs in All the Wrong Places: Use of GCPII Inhibitors Outside the Brain.
Journal: Neurochemical research
Published: September 15, 2019
Ghrelin agonist HM01 attenuates chemotherapy-induced neurotoxicity in rodent models.
Journal: European journal of pharmacology
Published: June 08, 2018
We're Not "DON" Yet: Optimal Dosing and Prodrug Delivery of 6-Diazo-5-oxo-L-norleucine.
Journal: Molecular cancer therapeutics
Published: November 22, 2017
FOLH1/GCPII is elevated in IBD patients, and its inhibition ameliorates murine IBD abnormalities.
Journal: JCI insight
Published: August 19, 2016
Still NAAG'ing After All These Years: The Continuing Pursuit of GCPII Inhibitors.
Journal: Advances in pharmacology (San Diego, Calif.)
Published: June 12, 2016
Preclinical pharmacology and pharmacokinetics of CERC-301, a GluN2B-selective N-methyl-D-aspartate receptor antagonist.
Journal: Pharmacology research & perspectives
Published: October 07, 2015
Sustained Accumulation of Microtubule-Binding Chemotherapy Drugs in the Peripheral Nervous System: Correlations with Time Course and Neurotoxic Severity.
Journal: Cancer research
Published: September 11, 2015
Gastrointestinal delivery of propofol from fospropofol: its bioavailability and activity in rodents and human volunteers.
Journal: Journal of translational medicine
Published: February 06, 2015
Pharmacokinetics and pharmacodynamics of the glutamate carboxypeptidase II inhibitor 2-MPPA show prolonged alleviation of neuropathic pain through an indirect mechanism.
Journal: The Journal of pharmacology and experimental therapeutics
Published: June 19, 2013
The orally active glutamate carboxypeptidase II inhibitor E2072 exhibits sustained nerve exposure and attenuates peripheral neuropathy.
Journal: The Journal of pharmacology and experimental therapeutics
Published: September 19, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026